ALK Inhibitors-Induced M Phase Delay Contributes to the Suppression of Cell Proliferation

Anaplastic lymphoma kinase (ALK), a receptor-type tyrosine kinase, is involved in the pathogenesis of several cancers. ALK has been targeted with small molecule inhibitors for the treatment of different cancers, but absolute success remains elusive. In the present study, the effects of ALK inhibitor...

Descripción completa

Detalles Bibliográficos
Autores principales: Munira, Sirajam, Yuki, Ryuzaburo, Saito, Youhei, Nakayama, Yuji
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7226408/
https://www.ncbi.nlm.nih.gov/pubmed/32344689
http://dx.doi.org/10.3390/cancers12041054

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7226408/
https://www.ncbi.nlm.nih.gov/pubmed/32344689
http://dx.doi.org/10.3390/cancers12041054

Ejemplares similares